Home > TERATEC FORUM > Workshops

TERATEC 2018 Forum
Workshop 2 - Wednesday, June 20 from 9h00 to 12h30


Applications de la Métagénomique à la découverte de nouveaux médicaments et diagnostics

Enterome is a clinical-stage biotech company pioneering innovative diagnostics and therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases and immuno-oncology indications. Enterome is operating in the very large space of microbiome-related diseases which has a tremendous potential in particular in the untapped market of immune-related indications, covering gastrointestinal, metabolic and immuno-oncology domains. Since 2012, Enterome is operating into the promising field of discovery and development of molecules produced by the microbiome. Enterome’s discovery platform has allowed demonstration that changes in the microbiome in patients can trigger changes in some of their key physiological mechanisms and activities, resulting in disease or contributing to its progression. Combining these assets with powerful in-house bioinformatics, drug discovery capabilities and an experienced management, Enterome has already demonstrated its deep understanding of human gut microbiome in health and disease and its ability to identify key microbiome-derived elements involved in major untreated pathologies, with the potential of creating next generation of biomarkers and drugs.

Biographie : Co-founder and CEO of Enterome, Pierre brings more than 20 years of successful experience in healthcare companies. Prior to starting Enterome in 2012, Pierre spent 2 years at Sanofi leading Business Development, Licensing and Acquisitions within the Ophthalmology division. He was in 2005 manager in residence at Sofinnova Partners (Paris) where he put in place the business plan, organization, and financing of a new company named Fovea Pharmaceuticals. Pierre has then served as COO of this retinal disease venture that was acquired in 2009 by Sanofi.
Earlier in his career, Pierre held various business or commercial positions in companies like UroGene, Fournier or Ethypharm. As a biotechnology entrepreneur, he has co-founded several companies including Maat Pharma, Targedys, Monabee, Athena, Cytis, and Opia. Pierre also sits on different company boards. Pierre holds an MBA from INSEAD and a PhD from the University of Paris.

Register now and get your badge here

  • TERATEC Forum is strictly reserved for professionals.
  • Participation to exhibition, conferences and workshops is free (subject to seats available)
  • On line registration is obligatory to attend exhibition, conferences or the workshops.
  • The Vigipirate security plan being raised to its highest level, it is mandatory to register online in advance and come with an identity card order to participate in TERATEC Forum.
  • The badge is free of charge and give you access to all events TERATEC Forum.

For any other information regarding the workshops, please contact :

Jean-Pascal JEGU
Tel : +33 (0)9 70 65 02 10
2, rue de la Piquetterie


© Ter@tec - All rights reserved - Lawful mention